Relay Therapeutics Management to Join September Healthcare Fireside Chats
Relay Therapeutics will participate in two September fireside chats at the Wells Fargo Healthcare Conference and the Morgan Stanley Global Healthcare Conference. The sessions will be webcast live, with archived replays available for up to 30 days. The company highlighted its Dynamo platform and clinical lead zovegalisib, a pan-mutant selective PI3Kα inhibitor in a Phase 3 breast cancer trial.